Anti-CHRNB3 antibodies are used in the immunodetection of the protein cholinergic receptor nicotinic beta 3 subunit. In humans, the canonical protein has a reported length of 458 amino acid residues and a mass of 52.7 kDa. Its subcellular localization is in the cell membrane. A member of the Ligand-gated ion channel (TC 1.A.9) protein family, CHRNB3 is known to be involved with chemical synaptic transmission and signal transduction pathways. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include acetylcholine receptor, neuronal nicotinic, beta-3 subunit, acetylcholine receptor, nicotinic, beta 3 (neuronal), cholinergic receptor, nicotinic beta 3, and neuronal acetylcholine receptor subunit beta-3. CHRNB3 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some CHRNB3 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.